Delivery Order SPE2DR25D1021-SPE2DR26FNL2S
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Mounjaro 5 mg/0.5 mL pen injections, with a firm fixed price ceiling value of $1,088.36. This non-competitive, competitively awarded delivery order is set to be completed by September 19, 2025, and will be fulfilled from the company's facility in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $1,840.88 to AmerisourceBergen Drug Corp for Mounjaro 7.5 mg/0.5 ml pen injections, with a completion date of September 30, 2025. This firm fixed-price delivery order, issued as a non-competitive award, represents a single pharmaceutical procurement under AmerisourceBergen's broader supply relationship with DLA. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 31, 2025, for the supply of Mounjaro 5 mg/0.5 ml pen injections with a ceiling value of $2,629.48. This is a firm fixed price delivery order with no set-aside designation, indicating competitive award through open competition. The order is set for completion by November 3, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,720.90 on July 28, 2025, for the supply of Mounjaro 5 mg/0.5 mL pen injections. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 29, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Mounjaro 5 mg/0.5 mL pen injections with a ceiling value of $3,816.64. The contract, which was competitively awarded without set-aside designation, is effective through September 24, 2025, and utilizes firm fixed pricing. AmerisourceBergen will perform this delivery order from its corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Mounjaro 5 mg/0.5 ml pen injections with a ceiling value of $2,821.20. This is a firm fixed price delivery order with an ultimate completion date of November 4, 2025, and was competitively awarded with no set-aside designation. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. As a delivery order, this award falls under a larger contract vehicle that provides the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 22, 2025, for the supply of Mounjaro 5 mg/0.5 mL pen injections. This firm fixed-price delivery order, valued at $1,632.54, represents a non-set-aside competitive award with an ultimate completion date of October 23, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $17,344.53 for Mounjaro 7.5 mg/0.5 mL pen injections on October 21, 2025, with an ultimate completion date of October 22, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designations and will be performed at the contractor's Conshohocken, Pennsylvania location. The award represents a single transaction under AmerisourceBergen's larger pharmaceutical supply vehicle...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Mounjaro 15 mg/0.5 mL pen injections valued at $6,422.82, with completion expected by September 29, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of Mounjaro 10 mg/0.5 mL pen injections valued at $3,041.27, with completion targeted for November 4, 2025. This non-set-aside, competitively awarded contract represents a firm fixed-price delivery order for pharmaceutical products to support federal medical procurement needs. The place of performance is located at AmerisourceBergen's corporate office in Conshohocken,...
- SPE2DR25D1021Indefinite Delivery Contract
- SPE2DR25D1021-SPE2DR26FNL2SDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Mounjaro 5 mg/0.5 ml pen injections valued at $1,707.87 with a firm fixed price structure. This non-set-aside competitive award was issued on October 22, 2025, with an ultimate completion date of October 23, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction fulfilling pharmaceutical supply requirements within the federal medical procurement system. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen supplies a broad portfolio of medications and medical supplies to support military and veteran healthcare systems. The company's federal contract awards demonstrate consistent capability in fulfilling competitive procurements across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, and medical devices for the Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 10/22/25 |